Open AccessAn umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy
Author(s) -
Stefano Celotto,
Nicola Veronese,
Mario Barbagallo,
Francesca Ometto,
Lee Smith,
Shahina Pardhan,
Yvonne Barnett,
Petre Cristian Ilie,
Pınar Soysal,
Erik Lagolio,
Peter K Kurotschka,
Roberto Tonelli,
Jacopo Demurtas
Publication year - 2020
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2020.12.018
Subject(s) - hydroxychloroquine , chloroquine , meta analysis , medicine , intensive care medicine , covid-19 , pathology , malaria , disease , infectious disease (medical specialty)
Hydroxychloroquine (HCQ) and chloroquine (CQ) are anti-malarial drugs frequently used in the rheumatologic field. They were recently identified as potential therapeutic options for Coronavirus Disease (COVID-19). The present study aims to map and grade the diverse health outcomes associated with HCQ/CQ using an umbrella review approach.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom